Saturday, November 21st, 2009

Posts Tagged ‘ ABT ’

Inflation May Show It’s Ugly Head, Big Week for Bank Earnings

Jul 13th, 2009 | By Christian Hill | Category: Financial News

Earnings Announcements: Novellus (NVLS)

Tuesday
Economic Reports: Core PPI, PPI, Retail Sales

Will this be the month that we finally see inflation take hold? If expectations come true, it very well could be. PPI is anticipated to show an increase of nearly 1%. Core PPI (which excludes food and energy costs) is expected to show an increase of 0.10%. Retail Sales are expected to post a surprising increase. Most reports I have seen show that retailers are still struggling. I don’t expect this report to beat expectations.

Earnings Announcements: Goldman Sachs (GS), Johnson and Johnson (JNJ), Yum Brands (YUM)



Inflation, Retail, and Housing Reports; Earnings Go Full Bore

Apr 13th, 2009 | By Christian Hill | Category: Financial News

This promises to be a very busy week with a full calendar of economic reports and earnings announcements, so let’s dive right in and highlight some of the more important ones.



Nothing Left for The Big Bad Wolf

Jan 20th, 2009 | By Christian Hill | Category: Financial News

The only reports on the calendar this week are housing related, and it got me thinking: what’s left? Pretty much nothing. As the fairy tale goes, the big bad wolf doesn’t even need to huff and puff; the house has already been blown down.



How To Find The Next Big Buyout Winner

Jan 15th, 2009 | By Jim Nelson | Category: Stock Market Investing

Investors can make astonishing gains in a matter of days if the company they own is bought at a premium by a larger firm. But how do you find these hidden gems ? Jim Nelson gives a list of six criteria that can help you pick a great buyout candidate.



Global Investment News Roundups Tuesday, January 13th, 2009

Jan 13th, 2009 | By William Patalon III | Category: Financial News

Rio Tinto Slows Expansion; Foreign Real Estate Investors Bullish; Abbott Laboratories Buys Advanced Medical Optics; Congo Jacks Primary Rate to 55%; Ford May Need TARP; LG Chem Gets a Charge from GM



It’s time to buy Isis Pharmaceuticals (ISIS)

Dec 19th, 2008 | By Laura Cadden | Category: Financial News

Isis Pharmaceuticals, Inc. (NASDAQ:ISIS) is a biopharmaceutical company that focuses entirely on RNA-based technologies and primarily, on antisense therapies.